These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 37849737)

  • 21. NOD-Like Receptor Protein 3 Inflammasome-Dependent IL-1β Accelerated ConA-Induced Hepatitis.
    Luan J; Zhang X; Wang S; Li Y; Fan J; Chen W; Zai W; Wang S; Wang Y; Chen M; Meng G; Ju D
    Front Immunol; 2018; 9():758. PubMed ID: 29692782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of NLRP3 inflammasome in the pathogenesis of rheumatic disease.
    Kong R; Sun L; Li H; Wang D
    Autoimmunity; 2022 Feb; 55(1):1-7. PubMed ID: 34713773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis.
    De Lauretis A; Sestini P; Pantelidis P; Hoyles R; Hansell DM; Goh NS; Zappala CJ; Visca D; Maher TM; Denton CP; Ong VH; Abraham DJ; Kelleher P; Hector L; Wells AU; Renzoni EA
    J Rheumatol; 2013 Apr; 40(4):435-46. PubMed ID: 23378460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifactorial functions of the inflammasome component NLRP3 in pathogenesis of chronic kidney diseases.
    Mulay SR
    Kidney Int; 2019 Jul; 96(1):58-66. PubMed ID: 30922667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fucoxanthin from microalgae Phaeodactylum tricornutum inhibits pro-inflammatory cytokines by regulating both NF-κB and NLRP3 inflammasome activation.
    Lee AH; Shin HY; Park JH; Koo SY; Kim SM; Yang SH
    Sci Rep; 2021 Jan; 11(1):543. PubMed ID: 33436909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
    Meloni F; Caporali R; Marone Bianco A; Paschetto E; Morosini M; Fietta AM; Patrizio V; Bobbio-Pallavicini F; Pozzi E; Montecucco C
    Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):111-8. PubMed ID: 15281432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expert consensus on the management of systemic sclerosis-associated interstitial lung disease.
    Rahaghi FF; Hsu VM; Kaner RJ; Mayes MD; Rosas IO; Saggar R; Steen VD; Strek ME; Bernstein EJ; Bhatt N; Castelino FV; Chung L; Domsic RT; Flaherty KR; Gupta N; Kahaleh B; Martinez FJ; Morrow LE; Moua T; Patel N; Shlobin OA; Southern BD; Volkmann ER; Khanna D
    Respir Res; 2023 Jan; 24(1):6. PubMed ID: 36624431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
    de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
    Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
    Yamakawa H; Takemura T; Iwasawa T; Yamanaka Y; Ikeda S; Sekine A; Kitamura H; Baba T; Iso S; Okudela K; Kuwano K; Ogura T
    BMC Pulm Med; 2018 Jan; 18(1):25. PubMed ID: 29382307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloid cell-specific deletion of Capns1 prevents macrophage polarization toward the M1 phenotype and reduces interstitial lung disease in the bleomycin model of systemic sclerosis.
    Zhang L; Zheng D; Yan Y; Yu Y; Chen R; Li Z; Greer PA; Peng T; Wang Q
    Arthritis Res Ther; 2022 Jun; 24(1):148. PubMed ID: 35729674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review: Serum biomarkers in idiopathic pulmonary fibrosis and systemic sclerosis associated interstitial lung disease - frontiers and horizons.
    Jee AS; Sahhar J; Youssef P; Bleasel J; Adelstein S; Nguyen M; Corte TJ
    Pharmacol Ther; 2019 Oct; 202():40-52. PubMed ID: 31153954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological management of systemic sclerosis associated interstitial lung disease.
    Dixon G; Adamali I; Adamali H; Barratt S; Gunarwardena H; Pauling JD
    Expert Opin Pharmacother; 2023 May; 24(7):815-824. PubMed ID: 37029594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of NLRP3 inflammasome in placentas from pregnant women with severe preeclampsia.
    C Weel I; Romão-Veiga M; Matias ML; Fioratti EG; Peraçoli JC; Borges VT; Araujo JP; Peraçoli MT
    J Reprod Immunol; 2017 Sep; 123():40-47. PubMed ID: 28915449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of pulmonary microvascular endothelial cells barrier dysfunction induced by LPS: The roles of ceramides and the Txnip/NLRP3 inflammasome.
    Ouyang H; Wang Y; Wu J; Ji Y
    Microvasc Res; 2023 May; 147():104491. PubMed ID: 36709858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Body mass index and adipokines/cytokines dysregulation in systemic sclerosis.
    Iannone F; Praino E; Rotondo C; Natuzzi D; Bizzoca R; Lacarpia N; Fornaro M; Cacciapaglia F
    Clin Exp Immunol; 2021 Nov; 206(2):153-160. PubMed ID: 34358345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
    Barnes H; Holland AE; Westall GP; Goh NS; Glaspole IN
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010908. PubMed ID: 29297205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis.
    Sun H; Zhu Y; Pan H; Chen X; Balestrini JL; Lam TT; Kanyo JE; Eichmann A; Gulati M; Fares WH; Bai H; Feghali-Bostwick CA; Gan Y; Peng X; Moore MW; White ES; Sava P; Gonzalez AL; Cheng Y; Niklason LE; Herzog EL
    Arthritis Rheumatol; 2016 May; 68(5):1251-61. PubMed ID: 26749424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The disconnect between visual assessment of air trapping and lung physiology for assessment of small airway disease in scleroderma-related interstitial lung disease: An observation from the Scleroderma Lung Study II Cohort.
    Bae SS; Pourzand L; Hyun Kim G; Villegas BE; Oh A; Furst DE; Goldin J; Tashkin DP
    J Scleroderma Relat Disord; 2022 Jun; 7(2):117-127. PubMed ID: 35585954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid alteration of serum interleukin-6 levels may predict the reactivity of i.v. cyclophosphamide pulse therapy in systemic sclerosis-associated interstitial lung disease.
    Numajiri H; Yoshizaki A; Fukasawa T; Ebata S; Nakamura K; Yamashita T; Saigusa R; Miura S; Hirabayashi M; Yoshizaki A; Sumida H; Asano Y; Kazoe Y; Mawatari K; Kitamori T; Sato S
    J Dermatol; 2018 Oct; 45(10):1221-1224. PubMed ID: 30051925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis.
    Sakamoto N; Kakugawa T; Hara A; Nakashima S; Yura H; Harada T; Ishimoto H; Yatera K; Kuwatsuka Y; Hara T; Ichinose K; Obase Y; Ishimatsu Y; Kohno S; Mukae H
    Respir Res; 2015 Dec; 16():148. PubMed ID: 26654954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.